Neurodegeneration, an progressive decline in the integrity of brain cells, presents a serious challenge to modern medicine. While there is currently no cure for neurodegenerative diseases, researchers are vigorously exploring innovative therapeutic approaches. One such avenue of research involves deschloroketamine, a modified form of the anesthetic